223 related articles for article (PubMed ID: 16524416)
1. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy.
Sun HY; Chen MY; Hsiao CF; Hsieh SM; Hung CC; Chang SC
Clin Microbiol Infect; 2006 Apr; 12(4):381-8. PubMed ID: 16524416
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus.
Huang YT; Hung CC; Liao CH; Sun HY; Chang SC; Chen YC
J Clin Microbiol; 2007 Sep; 45(9):2858-62. PubMed ID: 17596363
[TBL] [Abstract][Full Text] [Related]
3. Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy.
Sheng WH; Hung CC; Chen MY; Hsieh SM; Chang SC
Int J STD AIDS; 2002 Oct; 13(10):702-5. PubMed ID: 12396541
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART.
Chaiwarith R; Charoenyos N; Sirisanthana T; Supparatpinyo K
AIDS; 2007 Jan; 21(3):365-7. PubMed ID: 17255744
[TBL] [Abstract][Full Text] [Related]
6. Aetiology of cavitary lung lesions in patients with HIV infection.
Lin CY; Sun HY; Chen MY; Hsieh SM; Sheng WH; Lo YC; Hung CC; Chang SC
HIV Med; 2009 Mar; 10(3):191-8. PubMed ID: 19207599
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.
Chariyalertsak S; Supparatpinyo K; Sirisanthana T; Nelson KE
Clin Infect Dis; 2002 Jan; 34(2):277-84. PubMed ID: 11740718
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Skiest DJ; Hester LJ; Hardy RD
J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
[TBL] [Abstract][Full Text] [Related]
10. A 12-case series of Penicillium marneffei pneumonia.
Deesomchok A; Tanprawate S
J Med Assoc Thai; 2006 Apr; 89(4):441-7. PubMed ID: 16696387
[TBL] [Abstract][Full Text] [Related]
11. [Cryptococcus neoformans meningitis in a HIV negative miliary tuberculosis-suspected patient].
Aydemir H; Pişkin N; Oztoprak N; Celebi G; Tekin IO; Akduman D
Mikrobiyol Bul; 2008 Jul; 42(3):519-24. PubMed ID: 18822899
[TBL] [Abstract][Full Text] [Related]
12. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
13. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.
Vibhagool A; Sungkanuparph S; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C; Ingsathit A
Clin Infect Dis; 2003 May; 36(10):1329-31. PubMed ID: 12746781
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
Jongwutiwes U; Sungkanuparph S; Kiertiburanakul S
Jpn J Infect Dis; 2008 Mar; 61(2):111-5. PubMed ID: 18362398
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus.
Supparatpinyo K; Perriens J; Nelson KE; Sirisanthana T
N Engl J Med; 1998 Dec; 339(24):1739-43. PubMed ID: 9845708
[TBL] [Abstract][Full Text] [Related]
17. [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
Negroni R; Helou SH; López Daneri G; Robles AM; Arechavala AI; Bianchi MH
Rev Argent Microbiol; 2004; 36(3):113-7. PubMed ID: 15559192
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
19. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.
Aberg JA; Price RW; Heeren DM; Bredt B
J Infect Dis; 2002 Apr; 185(8):1179-82. PubMed ID: 11930330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
